Tweeting about Ebola: Analysis of Tweets from Africa, Europe and the United States During Two Months of the 2019 Ebola Virus Disease (EVD) Epidemic in the Democratic Republic of the Congo

2019 ◽  
Author(s):  
Chad Priest ◽  
Doyle Groves
Keyword(s):  
United States ◽  
Ebola Virus ◽  
Democratic Republic ◽  
Virus Disease ◽  
The United States ◽  
Ebola Virus Disease ◽  
Republic Of The Congo

scholarly journals PTSD, depression and anxiety in Ebola virus disease survivors in Beni town, Democratic Republic of the Congo

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Célestin Kaputu-Kalala-Malu ◽  
Eric Mafuta Musalu ◽  
Tim Walker ◽  
Olga Ntumba-Tshitenge ◽  
Steve Ahuka-Mundeke
Keyword(s):  
Ebola Virus ◽  
Democratic Republic ◽  
Short Term Memory ◽  
Virus Disease ◽  
Ebola Virus Disease ◽  
Depression And Anxiety ◽  
Short Term ◽  
Republic Of The Congo ◽  
Persistent Headache

Abstract Background Ebola Virus Disease (EVD) is a deadly and feared infectious disease, which can be responsible of debilitating physical and psychological sequelae in survivors including depression and anxiety disorders. Unfortunately, there are scarce data on survivor sequelae in Democratic Republic of the Congo. So this study assessed PTSD, depression and anxiety symptoms among EVD survivors enrolled in the follow-up program of the psychosocial care team of Beni town’s general hospital. Methods A cross-sectional study used consecutive sampling to recruit 144 Ebola virus disease survivors who came for follow up from October 23 to November 13; 2019. Basic socio-demographic data, presence of headache and short-term memory function were assessed. The Post-traumatic Checklist Scale and Hospital Anxiety and Depression Scale were used to assess psychological burden among participants. Descriptive statistics were used to summarized data and Pearson’s or likelihood chi-square were used to test association between psychiatric disorders and associated factors. Results The prevalence of PTSD, depression and anxiety was 24.3, 24.3 and 33.3% respectively. Being male (OR = 0.42, 95% CI: 0.16, 0.95, p = 0.049), suffering from persistent headache (OR = 2.62, 95% CI: 1.12, 6.14, p = 0.014), losing a loved one because of EVD (OR: 2.60, 95% CI: 1.11, 6.15, p = 0. 015) and being young − 18-24 years - (OR: 0. 261, 95% CI: 0. 08, 0.82, p = 0,026) were statistically associated with PTSD diagnosis. Having short-term memory impairment and suffering from persistent headache were statistically associated with depression and anxiety diagnoses (OR = 2.44, 95% CI: 1.03, 5.82, p = 0.026); (OR = 2.24, 95% CI: 1.04, 4.85, p = 0.025); (OR = 2.62, 95% CI: 1.12, 6.14, p = 0.014); (OR = 2.31, 95% CI: 1.06, 5.01, p = 0.020). Conclusion The prevalence of PTSD, depression and anxiety is high among EVD survivors. Development of specialized psychiatric services to sustain psychiatric and psychological health amongst survivors in the cultural context of the Eastern part of the DRC should be considered by the teams fighting against EVD in the DRC.

scholarly journals Contextual, Social and Epidemiological Characteristics of the Ebola Virus Disease Outbreak in Likati Health Zone, Democratic Republic of the Congo, 2017

2020 ◽  
Vol 8 ◽  
Author(s):  
Kathryn E. L. Grimes ◽  
Bonaventure Fuamba Ngoyi ◽  
Kristen B. Stolka ◽  
Jennifer J. Hemingway-Foday ◽  
Leopold Lubula ◽  
...  
Keyword(s):  
Ebola Virus ◽  
Democratic Republic ◽  
Virus Disease ◽  
Disease Outbreak ◽  
Ebola Virus Disease ◽  
Republic Of The Congo ◽  
Health Zone ◽  
Epidemiological Characteristics

scholarly journals Ebola Virus: a Clear and Present Danger

2014 ◽  
Vol 53 (1) ◽  
pp. 4-8 ◽  
Author(s):  
Eileen M. Burd
Keyword(s):  
United States ◽  
Ebola Virus ◽  
Virus Disease ◽  
The United States ◽  
Ebola Virus Disease ◽  
Burial Practices ◽  
Western Africa ◽  
Medical Facilities ◽  
Risk Patients ◽  
Clear And Present Danger

An epidemic of Ebola virus disease is occurring in Western Africa on a scale not seen before, particularly in the countries of Guinea, Liberia, and Sierra Leone. The continued spread is facilitated by insufficient medical facilities, poor sanitation, travel, and unsafe burial practices. Several patients diagnosed with Ebola virus disease in Africa have been evacuated to the United States for treatment, and several other patients have been diagnosed in the United States. It is important for laboratories to be aware of available tests, especially those granted emergency use authorization, as hospitals prepare protocols for the diagnosis and management of high-risk patients.

scholarly journals Infectious Disease Physician Assessment of Hospital Preparedness for Ebola Virus Disease

2015 ◽  
Vol 2 (3) ◽  
Author(s):  
Philip M. Polgreen ◽  
Scott Santibanez ◽  
Lisa M. Koonin ◽  
Mark E. Rupp ◽  
Susan E. Beekmann ◽  
...  
Keyword(s):  
Infectious Disease ◽  
United States ◽  
Ebola Virus ◽  
Virus Disease ◽  
The United States ◽  
Ebola Virus Disease ◽  
Teaching Hospitals ◽  
Emerging Infections ◽  
First Case ◽  
Hospital Preparedness

Abstract Background.  The first case of Ebola diagnosed in the United States and subsequent cases among 2 healthcare workers caring for that patient highlighted the importance of hospital preparedness in caring for Ebola patients. Methods.  From October 21, 2014 to November 11, 2014, infectious disease physicians who are part of the Emerging Infections Network (EIN) were surveyed about current Ebola preparedness at their institutions. Results.  Of 1566 EIN physician members, 869 (55.5%) responded to this survey. Almost all institutions represented in this survey showed a substantial degree of preparation for the management of patients with suspected and confirmed Ebola virus disease. Despite concerns regarding shortages of personal protective equipment, approximately two thirds of all respondents reported that their facilities had sufficient and ready availability of hoods, full body coveralls, and fluid-resistant or impermeable aprons. The majority of respondents indicated preference for transfer of Ebola patients to specialized treatment centers rather than caring for them locally. In general, we found that larger hospitals and teaching hospitals reported higher levels of preparedness. Conclusions.  Prior to the Centers for Disease Control and Prevention's plan for a tiered approach that identified specific roles for frontline, assessment, and designated treatment facilities, our query of infectious disease physicians suggested that healthcare facilities across the United States were making preparations for screening, diagnosis, and treatment of Ebola patients. Nevertheless, respondents from some hospitals indicated that they were relatively unprepared.

scholarly journals Ptsd, Depression and Anxiety In Ebola Virus Disease Survivors In Beni Town, Democratic Republic of the Congo

2020 ◽  
Author(s):  
CELESTIN KAPUTU-KALALA-MALU ◽  
Eric Mafuta Musalu ◽  
Tim Walker ◽  
Olga Ntumba-Tshitenge ◽  
Steve Ahuka-Mundeke
Keyword(s):  
Ebola Virus ◽  
Democratic Republic ◽  
Short Term Memory ◽  
Virus Disease ◽  
Ebola Virus Disease ◽  
Depression And Anxiety ◽  
Short Term ◽  
Term Memory ◽  
Republic Of The Congo ◽  
Persistent Headache

Abstract Background Ebola Virus Disease (EVD) is a deadly and feared infectious disease, which can be responsible of debilitating physical and psychological sequelae in survivors including depression and anxiety disorders. Unfortunately, there are scarce data on survivor sequelae in Democratic Republic of the Congo. So this study assessed PTSD, depression and anxiety symptoms among EVD survivors enrolled in the follow-up program of the psychosocial care team of Beni town’s general hospital. Methods A cross-sectional study used consecutive sampling to recruit 144 Ebola virus disease survivors from October 23 to November 13; 2019. Basic socio-demographic data, presence of headache and short-term memory function were assessed. The Post-traumatic Checklist Scale and Hospital Anxiety and Depression Scale were used to assess psychological burden among participants. Descriptive statistics and a binary logistic regression model were used for analysis. Results The prevalence of PTSD, depression and anxiety was 24.3%, 24.3% and 33.3% respectively. Being male (p = 0.049 ; OR = 0. 42 (CI : 0. 16–0.95), suffering from persistent headache (p = 0. 014 OR = 2.62 CI (1.12–6.14), losing a loved one because of EVD (p = 0. 015 ; OR : 2.60 (CI : 1.11–6.15) and being young − 18–24 years - (p = 0,026 ; OR : 0. 261 (IC : 0. 018-0.055).) were statistically associated with PTSD diagnosis. Having short-term memory impairment and suffering from persistent headache were statistically associated with depression and anxiety diagnoses (p = 0.026 OR = 2,44 (CI : 1.03–5.82) ; (p = 0. 025 OR = 2.24 (CI : 1.04–4.85) ; (p = 0.014 OR = 2.62 (CI : 1.12–6.14) ; (p = 0. 020 OR = 2.31 (CI : 1.06–5.01) Conclusion The prevalence of PTSD, depression and anxiety is high among EVD survivors. Development of specialized psychiatric services to sustain psychiatric and psychological health amongst survivors in the cultural context of the Eastern part of the DRC should be considered by the teams fighting against EVD in the DRC.

2018 Ebola virus disease outbreak in Équateur Province, Democratic Republic of the Congo: a retrospective genomic characterisation

2019 ◽  
Vol 19 (6) ◽  
pp. 641-647 ◽  
Author(s):  
Placide Mbala-Kingebeni ◽  
Catherine B Pratt ◽  
Michael R Wiley ◽  
Moussa M Diagne ◽  
Sheila Makiala-Mandanda ◽  
...  
Keyword(s):  
Ebola Virus ◽  
Democratic Republic ◽  
Virus Disease ◽  
Disease Outbreak ◽  
Ebola Virus Disease ◽  
Republic Of The Congo

scholarly journals Clinical Evaluation of QuickNaviTM-Ebola in the 2018 Outbreak of Ebola Virus Disease in the Democratic Republic of the Congo

Viruses ◽  
2019 ◽  
Vol 11 (7) ◽  
pp. 589 ◽  
Author(s):  
Sheila Makiala ◽  
Daniel Mukadi ◽  
Anja De Weggheleire ◽  
Shino Muramatsu ◽  
Daisuke Kato ◽  
...  
Keyword(s):  
West Africa ◽  
Diagnostic Tests ◽  
Ebola Virus ◽  
Democratic Republic ◽  
Virus Disease ◽  
Point Of Care ◽  
Rapid Diagnostic Tests ◽  
Ebola Virus Disease ◽  
Blood Samples ◽  
Republic Of The Congo

The recent large outbreaks of Ebola virus disease (EVD) in West Africa and the Democratic Republic of the Congo (DRC) have highlighted the need for rapid diagnostic tests to control this disease. In this study, we clinically evaluated a previously developed immunochromatography-based kit, QuickNaviTM-Ebola. During the 2018 outbreaks in DRC, 928 blood samples from EVD-suspected cases were tested with QuickNaviTM-Ebola and the WHO-approved GeneXpert. The sensitivity and specificity of QuickNaviTM-Ebola, estimated by comparing it to GeneXpert-confirmed cases, were 85% (68/80) and 99.8% (846/848), respectively. These results indicate the practical reliability of QuickNaviTM-Ebola for point-of-care diagnosis of EVD.

Sign in / Sign up

Export Citation Format

Share Document